Roundtables: Looking Toward Potential Latent Toxicities for PSMA TRPs

Time: 12:15 pm
day: Day One LSC AM

Details:

  • As more patients are receiving PSMA radiopharmaceuticals, more monitoring is required
  • Examining radiation dose and potential secondary malignancies
  • Discussing preventative steps